Table 3.
Category | Univariate Cox analysis (DFS) | Multivariate Cox analysis (DFS) | |||
---|---|---|---|---|---|
Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | ||
Age at menarche | ≤ 14 years vs. >14 years | 1.696 (0.823–3.491) | 0.152 | – | – |
Menopause status | Premenopausal vs. menopausal | 1.282 (0.623–2.641) | 0.5 | – | – |
Age | ≤ 50 years vs. >50 years | 0.832 (0.404–1.715) | 0.619 | 0.887 (0.391–2.010) | 0.774 |
Family history | Breast cancer vs. no history | 0.556 (0.212–1.454) | 0.231 | – | – |
pT | pTis/pT1 vs. pT2/3 | 1.966 (0.875–4.416) | 0.102 | 1.027 (0.431–2.448) | 0.952 |
BMI | <24 vs. ≥24 | 1.236 (0.588–2.600) | 0.576 | – | – |
Number of pregnancies | ≤ 2 times vs. >2 times | 1.758 (0.823–3.757) | 0.145 | – | – |
pN | LN-negative vs. LN-positive | 0.291 (0.141–0.599) | 0.001 | 0.361 (0.166–0.787) | 0.01 |
Histopathology | Lobular component vs. no lobular component | 0.730 (0.279–1.907) | 0.521 | 0.746 (0.252–2.203) | 0.595 |
Bilateral ER consistency | Bilateral concordant vs. bilateral discordant | 0.951 (0.409–2.217) | 0.907 | – | – |
ER status | Positive vs. negative | 0.506 (0.207–1.240) | 0.136 | 0.473 (0.167–1.338) | 0.158 |
HER2 status | Positive vs. negative | 0.614 (0.263–1.430) | 0.258 | 0.531 (0.208–1.357) | 0.186 |
BRCA1/2 status | Wild type vs. mutated | 1.068 (0.409–2.790) | 0.894 | 0.585 (0.431–2.448) | 0.355 |
LVI | Positive vs. negative | 0.664 (0.304–1.450) | 0.304 | – | – |
ER status for 3y DFS | Positive vs. negative | 0.324 (0.126–0.837) | 0.020 | 0.179 (0.050–0.644) | 0.008 |